References
Adya R, Tan BK, & Randeva HS (2015). Differential effects of leptin and adiponectin in endothelial angiogenesis. Journal of diabetes research 2015: 648239.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 101: 15718-15723.
Bagarolli RA, Tobar N, Oliveira AG, Araujo TG, Carvalho BM, Rocha GZ, et al. (2017). Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. The Journal of nutritional biochemistry 50: 16-25.
Bond DM, Morris JM, & Nassar N (2017). Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: a randomised controlled trial. BMC pregnancy and childbirth 17: 148.
Boutagy NE, McMillan RP, Frisard MI, & Hulver MW (2016). Metabolic endotoxemia with obesity: Is it real and is it relevant? Biochimie 124: 11-20.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. (2007). Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772.
Castaner O, Goday A, Park YM, Lee SH, Magkos F, Shiow STE, et al. (2018). The Gut Microbiome Profile in Obesity: A Systematic Review. International journal of endocrinology 2018: 4095789.
Cavalcante RGS, de Albuquerque TMR, de Luna Freire MO, Ferreira GAH, Carneiro Dos Santos LA, Magnani M, et al. (2019). The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats. Nutrition, metabolism, and cardiovascular diseases : NMCD 29: 1408-1417.
Crovesy L, Masterson D, & Rosado EL (2020). Profile of the gut microbiota of adults with obesity: a systematic review. European journal of clinical nutrition.
Chakraborti CK (2015). New-found link between microbiota and obesity. World journal of gastrointestinal pathophysiology 6: 110-119.
Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, et al. (2019). Next generation probiotics in disease amelioration. Journal of food and drug analysis 27: 615-622.
Chen LH, Chen YH, Cheng KC, Chien TY, Chan CH, Tsao SP, et al. (2018). Antiobesity effect of Lactobacillus reuteri 263 associated with energy metabolism remodeling of white adipose tissue in high-energy-diet-fed rats. The Journal of nutritional biochemistry 54: 87-94.
Choi WJ, Dong HJ, Jeong HU, Jung HH, Kim YH, & Kim TH (2019). Antiobesity Effects of Lactobacillus plantarum LMT1-48 Accompanied by Inhibition of Enterobacter cloacae in the Intestine of Diet-Induced Obese Mice. Journal of medicinal food 22: 560-566.
Daniali M, Nikfar S, & Abdollahi M (2020). A brief overview on the use of probiotics to treat overweight and obese patients. Expert review of endocrinology & metabolism 15: 1-4.
De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. (2010). Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the United States of America 107:14691-14696.
Dhariwal A, Chong J, Habib S, King IL, Agellon LB, & Xia J (2017). MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic acids research 45: W180-W188.
Didion SP (2017). Unraveling the Role and Complexities of Inflammation in Hypertension. Hypertension 70: 700-702.
Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, Magness S, et al. (2010). High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PloS one 5: e12191.
Eckel RH, Alberti KG, Grundy SM, & Zimmet PZ (2010). The metabolic syndrome. The lancet 375:181-183.
El Hage R, Hernandez-Sanabria E, & Van de Wiele T (2017). Emerging Trends in ”Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications. Frontiers in microbiology 8: 1889.
Esser N, Legrand-Poels S, Piette J, Scheen AJ, & Paquot N (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical practice 105: 141-150.
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110: 9066-9071.
Fasano A (2017). Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg? The American journal of clinical nutrition 105: 3-4.
Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, & Colecchia A (2014). Gut microbiota and metabolic syndrome. World journal of gastroenterology 20: 16079-16094.
Gil-Cardoso K, Gines I, Pinent M, Ardevol A, Blay M, & Terra X (2016). Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutrition research reviews 29:234-248.
Greenblum S, Turnbaugh PJ, & Borenstein E (2012). Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proceedings of the National Academy of Sciences of the United States of America 109: 594-599.
Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, et al. (2009). High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137: 1716-1724 e1711-1712.
Huby AC, Otvos L, Jr., & Belin de Chantemele EJ (2016). Leptin Induces Hypertension and Endothelial Dysfunction via Aldosterone-Dependent Mechanisms in Obese Female Mice. Hypertension 67: 1020-1028.
Jang HM, Han SK, Kim JK, Oh SJ, Jang HB, & Kim DH (2019). Lactobacillus sakei Alleviates High-Fat-Diet-Induced Obesity and Anxiety in Mice by Inducing AMPK Activation and SIRT1 Expression and Inhibiting Gut Microbiota-Mediated NF-kappaB Activation. Molecular nutrition & food research 63:e1800978.
Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, & Thorngren-Jerneck K (2012). The microbiota of the gut in preschool children with normal and excessive body weight. Obesity 20: 2257-2261.
Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, et al. (2013). Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498: 99-103.
Kawano M, Miyoshi M, Ogawa A, Sakai F, & Kadooka Y (2016). Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet. Journal of nutritional science 5: e23.
Kim AY, Park YJ, Pan X, Shin KC, Kwak SH, Bassas AF, et al. (2015). Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nature communications 6: 7585.
Kwon J, Kim B, Lee C, Joung H, Kim BK, Choi IS, et al. (2020). Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1alpha pathway by probiotics treatment in mice. PloS one 15: e0228932.
Lee IS, Shin G, & Choue R (2010). Shifts in diet from high fat to high carbohydrate improved levels of adipokines and pro-inflammatory cytokines in mice fed a high-fat diet. Endocrine journal 57: 39-50.
Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, & Gordon JI (2005). Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences of the United States of America 102: 11070-11075.
Lim SM, Jeong JJ, Woo KH, Han MJ, & Kim DH (2016). Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutrition research 36: 337-348.
Lim SM, & Kim DH (2017). Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-kappaB activation and lipopolysaccharide production by gut microbiota. Nutrition research 41: 86-96.
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. (2016). The gut microbiota and host health: a new clinical frontier. Gut 65: 330-339.
Martin R, Langa S, Reviriego C, Jiminez E, Marin ML, Xaus J, et al. (2003). Human milk is a source of lactic acid bacteria for the infant gut. The Journal of pediatrics 143: 754-758.
Rivero-Gutierrez B, Gamez-Belmonte R, Suarez MD, Lavin JL, Aransay AM, Olivares M, et al. (2017). A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. Molecular nutrition & food research 61.
Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Romero M, Olivares M, et al. (2018). The Probiotic Lactobacillus fermentum Prevents Dysbiosis and Vascular Oxidative Stress in Rats with Hypertension Induced by Chronic Nitric Oxide Blockade. Molecular nutrition & food research 62:e1800298.
Rodriguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, et al. (2017). Differential intestinal anti-inflammatory effects of Lactobacillus fermentum and Lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Molecular nutrition & food research 61.
Rodríguez-Nogales A, Algieri F, Vezza T, Garrido-Mesa N, Olivares M, Comalada M, et al. (2015). The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties. Food & Function 6:1176-1184.
Rogero MM, & Calder PC (2018). Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. Nutrients 10.
Saklayen MG (2018). The Global Epidemic of the Metabolic Syndrome. Current hypertension reports 20: 12.
Saunders KH, Umashanker D, Igel LI, Kumar RB, & Aronne LJ (2018). Obesity Pharmacotherapy. The Medical clinics of North America 102: 135-148.
Shepherd PR, & Kahn BB (1999). Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. The New England journal of medicine 341: 248-257.
Teixeira TF, Souza NC, Chiarello PG, Franceschini SC, Bressan J, Ferreira CL, et al. (2012). Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clinical nutrition 31:735-740.
Tenorio-Jimenez C, Martinez-Ramirez MJ, Gil A, & Gomez-Llorente C (2020). Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients 12.
Tomaro-Duchesneau C, Saha S, Malhotra M, Jones ML, Labbe A, Rodes L, et al. (2014). Effect of orally administered L. fermentum NCIMB 5221 on markers of metabolic syndrome: an in vivo analysis using ZDF rats. Applied microbiology and biotechnology 98: 115-126.
Toral M, Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Utrilla MP, et al. (2014). The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clinical Science 127:33-45.
Toral M, Robles-Vera I, Romero M, de la Visitacion N, Sanchez M, O’Valle F, et al. (2019). Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33: 10005-10018.
Vargas E, Podder V, & Carrillo Sepulveda MA (2020). Physiology, Glucose Transporter Type 4 (GLUT4). In StatPearls. Treasure Island (FL).
Vezza T, Rodriguez-Nogales A, Algieri F, Garrido-Mesa J, Romero M, Sanchez M, et al. (2019). The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties. Pharmacological research 150: 104487.
Walther G, Obert P, Dutheil F, Chapier R, Lesourd B, Naughton G, et al. (2015). Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study. Arteriosclerosis, thrombosis, and vascular biology 35:1022-1029.
Wang Q, Garrity GM, Tiedje JM, & Cole JR (2007). Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and environmental microbiology 73: 5261-5267.
Yang JY, Lee YS, Kim Y, Lee SH, Ryu S, Fukuda S, et al. (2017). Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal immunology 10: 104-116.
Zarzuelo MJ, Jiménez R, Galindo P, Sánchez M, Nieto A, Romero M, et al. (2011). Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats. Hypertension 58: 733-743.
Zhu K, Tan F, Mu J, Yi R, Zhou X, & Zhao X (2019). Anti-Obesity Effects of Lactobacillus fermentum CQPC05 Isolated from Sichuan Pickle in High-Fat Diet-Induced Obese Mice through PPAR-alpha Signaling Pathway. Microorganisms 7.
Table 1. Primer sequences used in RT-qPCR assays